2018

August

Cyclin dependent kinase inhibitor 1 C is a female-specific marker of left ventricular function after acute myocardial infarction
Lalem T, Zhang L, Scholz M, Burkhardt R, Saccheti V, Teren A, Thiery J, Devaux Y; Cardiolinc™ network (www.cardiolinc.org). Int J Cardiol. 2018. pii: S0167-5273(18)32556-7.

MicroRNA-24 and the Diabetic Heart
Rienks M, Joshi A, Mayr M. JACC Basic Transl Sci. 2018, 3(3):363-365.

RNA therapeutics for heart disease
De Majo F, De Windt LJ. Biochem Pharmacol. 2018, 155:468-478.

July

The association between plasma miR-122-5p release pattern at admission and all-cause mortality or shock after out-of-hospital cardiac arrest
Gilje P, Frydland M, Bro-Jeppesen J, Dankiewicz J, Friberg H, Rundgren M, Devaux Y, Stammet P, Al-Mashat M, Jögi J, Kjaergaard J, Hassager C, Erlinge D. Biomarkers. 2018, 1-25.

Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy
Toro R, Blasco-Turrión S, Morales-Ponce FJ, Gonzalez P, Martínez-Camblor P, López-Granados A, Brugada R, Campuzano O, Pérez-Serra A, Rosa Longobardo F, Mangas A, Llorente-Cortes V, de Gonzalo-Calvo D. J Mol Med (Berl). 2018.

MicroRNA interactome analysis predicts post-transcriptional regulation of ADRB2 and PPP3R1 in the hypercholesterolemic myocardium
Ágg B, Baranyai T, Makkos A, Vető B, Faragó N, Zvara Á, Giricz Z, Veres DV, Csermely P, Arányi T, Puskás LG, Varga ZV, Ferdinandy P. Sci Rep. 2018, 8(1):10134.

MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium
Joris V, Gomez EL, Menchi L, Lobysheva I, Di Mauro V, Esfahani H, Condorelli G, Balligand JL, Catalucci D, Dessy C. Arterioscler Thromb Vasc Biol. 2018, pii: ATVBAHA.118.311145.

RNA Therapeutics in Cardiovascular Disease
Lucas T, Bonauer A, Dimmeler S. Circ Res. 2018, 123(2):205-220.

MicroRNA-155 Amplifies Nitric Oxide/cGMP Signaling and Impairs Vascular Angiotensin II Reactivity in Septic Shock
Vasques-Nóvoa F, Laundos TL, Cerqueira RJ, Quina-Rodrigues C, Soares-Dos-Reis R, Baganha F, Ribeiro S, Mendonça L, Gonçalves F, Reguenga C, Verhesen W, Carneiro F, Paiva JA, Schroen B, Castro-Chaves P, Pinto-do-Ó P, Nascimento DS, Heymans S, Leite-Moreira AF, Roncon-Albuquerque R Jr. Crit Care Med. 2018.

June

Non-coding RNAs in aneurysmal aortopathy
Spin JM, Li DY, Maegdefessel L, Tsao PS. Vascul Pharmacol. 2018, pii: S1537-1891(17)30367-1.

Extracellular Vesicle Crosstalk Between the Myocardium and Immune System Upon Infarction
Burnap SA, Mayr M. Circ Res. 2018, 123(1):15-17.

miR-210 Enhances the Therapeutic Potential of Bone-Marrow-Derived Circulating Proangiogenic Cells in the Setting of Limb Ischemia
Besnier M, Gasparino S, Vono R, Sangalli E, Facoetti A, Bollati V, Cantone L, Zaccagnini G, Maimone B, Fuschi P, Da Silva D, Schiavulli M, Aday S, Caputo M, Madeddu P, Emanueli C, Martelli F, Spinetti G. Mol Ther. 2018, pii: S1525-0016(18)30262-4.

Study Design and qPCR Data Analysis Guidelines for Reliable Circulating miRNA Biomarker Experiments: A Review
de Ronde MWJ, Ruijter JM, Moerland PD, Creemers EE, Pinto-Sietsma SJ. Clin Chem. 2018, pii: clinchem.2017.285288.

A systems immunology approach identifies the collective impact of 5 miRs in Th2 inflammation
Kılıç A, Santolini M, Nakano T, Schiller M, Teranishi M, Gellert P, Ponomareva Y, Braun T, Uchida S, Weiss ST, Sharma A, Renz H. JCI Insight. 2018, 3(11). pii: 97503.

Long Non-coding RNAs in Endothelial Biology
Weirick T, Militello G, Uchida S. Front Physiol. 2018, 9:522.

Expanding the horizons of microRNA bioinformatics
Huntley RP, Kramarz B, Sawford T, Umrao Z, Kalea AZ, Acquaah V, Martin MJ, Mayr M, Lovering RC. RNA. 2018, pii: rna.065565.118.

Non-coding RNAs in vascular disease – from basic science to clinical applications: Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology
Fiedler J, Baker AH, Dimmeler S, Heymans S, Mayr M, Thum T. Cardiovasc Res. 2018.

Lnc'ing Ca2+, SERCA and cardiac disease
Vervliet T, Robinson EL, Roderick HL. Cell Calcium. 2018, pii: S0143-4160(18)30086-1.

May

Vascular extracellular vesicles in comorbidities of heart failure with preserved ejection fraction in men and women: The hidden players. A mini review
Gohar A, de Kleijn DPV, Hoes AW, Rutten FH, Hilfiker-Kleiner D, Ferdinandy P, Sluijter JPG, den Ruijter HM. Vascul Pharmacol. 2018, pii: S1537-1891(17)30466-4.

Non-coding RNAs and exercise: pathophysiological role and clinical application in the cardiovascular system
Gomes CPC, de Gonzalo-Calvo D, Toro R, Fernandes T, Theisen D, Wang D-ZDevaux Y; on behalf of the Cardiolinc™ network. Clin Sci. 2018, 132(9)925-942.

Circulating microRNAs as emerging cardiac biomarkers responsive to acute exercise
de Gonzalo-Calvo D, Dávalos A, Fernández-Sanjurjo M, Amado-Rodríguez L, Díaz-Coto S, Tomás-Zapico C, Montero A, García-González Á, Llorente-Cortés V, Heras ME, Boraita Pérez A, Díaz-Martínez ÁE, Úbeda N, Iglesias-Gutiérrez E. Int J Cardiol. 2018, 264:130-136.

MicroRNA-221/222 Expression in Atherosclerotic Coronary Artery Plaque and Peripheral Blood
Bildirici AE, Arslan S, Özbilüm Şahin N, Berkan Ö, Beton O, Yılmaz MB. Biomarkers. 2018, 8:1-19.

A Breath of Fresh Air(n) in Molecular Cardiology: Airn Long Noncoding RNA Regulates Cardiomyocyte Resistance to Stress and Igf2bp2 Translation
Greco S, Martelli F. Circ Res. 2018, 122(10):1321-1323.

Airn Regulates Igf2bp2 Translation in Cardiomyocytes
Hosen MR, Militello G, Weirick T, Ponomareva Y, Dassanayaka S, Moore JB 4th, Döring C, Wysoczynski M, Jones SP, Dimmeler S, Uchida SCirc Res. 2018, 122(10):1347-1353.

April

Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation
Doñate Puertas R, Jalabert A, Meugnier E, Euthine V, Chevalier P, Rome S. PLoS One. 2018, 13(5):e0196666.

RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling
van den Hoogenhof MM, Beqqali A, Amin AS, van der Made I, Aufiero S, Khan MA, Schumacher CA, Remme CA, Backs J, Verkerk AO, Baartscheer A, Pinto YMCreemers EECirculation. 2018.

miR-22 in Smooth Muscle Cells: A Potential Therapy for Cardiovascular Disease
Huang ZP, Wang DZ. Circulation. 2018, 137(17):1842-1845.

Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalised medicine?
de Gonzalo-Calvo D, Vea A, Bär C, Fiedler J, Couch L, Brotons C, Llorente-Cortés V, Thum T. European Heart Journal. 2018.

Long Non-Coding RNAs in Vascular Inflammation
Haemmig S, Simion V, Feinberg MW. Front Cardiovasc Med. 2018.

H19 Induces Abdominal Aortic Aneurysm Development and Progression
Li DY, Busch A, Jin H, Chernogubova E, Pelisek J, Karlsson J, Sennblad B, Liu S, Lao S, Hofmann P, Bäcklund A, Eken SM, Roy J, Eriksson P, Dacken B, Ramanujam D, Dueck A, Engelhardt S, Boon RA, Eckstein HH, Spin JM, Tsao PS, Maegdefessel L. Circulation. 2018.

Mirna-Mediated Mechanisms of Cardiac Protection in Ischemic and Remote Ischemic Preconditioning - A Qualitative Systematic Review
Kohns M, Huhn R, Bauer I, Brandenburger T. Shock. 2018.

A novel long non-coding RNA Myolinc regulates myogenesis through TDP-43 and Filip1
Militello G, Hosen MR, Ponomareva Y, Gellert P, Weirick T, John D, Hindi SM, Mamchaoui K, Mouly V, Döring C, Zhang L, Nakamura M, Kumar A, Fukada SI, Dimmeler S, Uchida S. J Mol Cell Biol. 2018.

March

UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease
Elia L, Kunderfranco P, Carullo P, Vacchiano M, Farina FM, Hall IF, Mantero S, Panico C, Papait R, Condorelli G, Quintavalle M. J Clin Invest. 2018.

MicroRNA-21 and the Vulnerability of Atherosclerotic Plaques
Barwari T, Rienks M, Mayr M. Mol Ther. 2018.

Cardiac circRNAs arise mainly from constitutive exons rather than alternatively spliced exons
Aufiero S, van den Hoogenhof MMG, Reckman YJ, Beqqali A, van der Made I, Kluin J, Khan MAF, Pinto YM, Creemers EE. RNA. 2018.

Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities
Schiattarella GG, Madonna R, Van Linthout S, Thum T, Schulz R, Ferdinandy P, Perrino C. Vascul Pharmacol. 2018.

The long noncoding RNA landscape in cardiovascular disease: a brief update
Salamon I, Saccani Jotti G, Condorelli G. Curr Opin Cardiol. 2018.

Redefining biomarkers in heart failure
Correale M, Monaco I, Brunetti ND, Di Biase M, Metra M, Nodari S, Butler J, Gheorghiade M; Master Program Students on Drug Development for Heart Failure. Heart Fail Rev. 2018.

An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm
Lino Cardenas CL, Kessinger CW, Cheng Y, MacDonald C, MacGillivray T, Ghoshhajra B, Huleihel L, Nuri S, Yeri AS, Jaffer FA, Kaminski N, Ellinor P, Weintraub NL, Malhotra R, Isselbacher EM, Lindsay ME. Nat Commun. 2018, 9(1):1009.

Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury
Ong SB, Katwadi K, Kwek XY, Ismail NI, Chinda K, Ong SG, Hausenloy DJ. Expert Opin Ther Targets. 2018, 22(3):247-261.

Circular RNAs in the cardiovascular system
Gomes CPC, Salgado-Somoza A, Creemers EE, Dieterich C, Lustrek M, Devaux Y; on behalf of the Cardiolinc™ networkNon-Coding RNA Res. 2018.

3-gene panel improves the prediction of left ventricular dysfunction after acute myocardial infarction
Boileau A, Lalem T, Vausort M, Zhang L, Devaux Y; Cardiolinc™ network (www.cardiolinc.org). Int J Cardiol. 2018, 254:28-35.

February

MicroRNA as Crucial Regulators of Gene Expression in Estradiol-Treated Human Endothelial Cells
Vidal-Gómez X, Pérez-Cremades D, Mompeón A, Dantas AP, Novella S, Hermenegildo C. Cell Physiol Biochem. 2018, 45(5):1878-1892.

Endogenous Heparin Interferes with Quantification of MicroRNAs by RT-qPCR
Boileau A, Lino Cardenas CL, Lindsay ME, Devaux Y; Cardiolinc™ network. Clin Chem. 2018, pii: clinchem.2017.284653. 

Airn Regulates Igf2bp2 Translation in Cardiomyocytes
Hosen MR, Militello G, Weirick TM, Ponomareva Y, Dassanayaka S, Moore JB, Doering C, Wysoczynski M, Jones SP, Dimmeler S, Uchida S. Circ Res. 2018, pii: CIRCRESAHA.117.312215.

Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle
Rech M, Barandiaran Aizpurua A, van Empel V, Van Bilsen M, Schroen B. Cardiovasc Res. 2018.

LncRNAs in vascular biology and disease
Simion V, Haemmig S, Feinberg MW. Vascul Pharmacol. 2018, pii: S1537-1891(17)30441-X.

Decreased FENDRR and LincRNA-p21 expression in atherosclerotic plaque
Çekin N, Özcan A, Göksel S, Arslan S, Pınarbaşı E, Berkan Ö. Anatol J Cardiol. 2018, 19(2):131-136.

miRNA as a New Regulatory Mechanism of Estrogen Vascular Action
Pérez-Cremades D, Mompeón A, Vidal-Gómez X, Hermenegildo C, Novella S. Int J Mol Sci. 2018, 19(2). pii: E473.

RNA Editing: Unexplored Opportunities in the Cardiovascular System
Uchida S, Jones SP. Circ Res. 2018, 122(3):399-401.

January

Local Delivery of miR-21 Stabilizes Fibrous Caps in Vulnerable Atherosclerotic Lesions
Jin H, Li DY, Chernogubova E, Sun C, Busch A, Eken SM, Saliba-Gustafsson P, Winter H, Winski G, Raaz U, Schellinger IN, Simon N, Hegenloh R, Matic LP, Jagodic M, Ehrenborg E, Pelisek J, Eckstein HH, Hedin U, Backlund A, Maegdefessel L. Mol Ther. 2018.

Circulating Circles Predict Postoperative Atrial Fibrillation
Reckman YJ, Creemers EE. J Am Heart Assoc. 2018, 7(2). pii: e008261.

Localization of transcripts, translation, and degradation for spatiotemporal sarcomere maintenance
Lewis YE, Moskovitz A, Mutlak M, Heineke J, Caspi LH, Kehat I. J Mol Cell Cardiol. 2018, S0022-2828(18)30021-X.

The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL2
Neumann P, Jaé N, Knau A, Glaser SF, Fouani Y, Rossbach O, Krüger M, John D, Bindereif A, Grote P, Boon RA, Dimmeler SNat Commun. 2018, 16;9(1):237.

Deep Computational Circular RNA Analytics from RNA-seq Data
Jakobi T, Dieterich CMethods Mol Biol. 2018, 1724:9-25.